Charles Schwab Investment Management Inc Neuro Pace Inc Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Neuro Pace Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 36,537 shares of NPCE stock, worth $396,426. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,537
Previous 36,537
-0.0%
Holding current value
$396,426
Previous $276,000
7.97%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NPCE
# of Institutions
52Shares Held
21.3MCall Options Held
1.3KPut Options Held
100-
Kck Ltd. Tortola, D85.62MShares$61 Million77.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$37 Million0.56% of portfolio
-
Morgan Stanley New York, NY2.49MShares$27.1 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$26.4 Million1.44% of portfolio
-
Kent Lake Pr LLC Anasco, PR1.25MShares$13.6 Million3.46% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $270M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...